Screener
Revolution Medicines, Inc. RVMD Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
FAQ
- What is Revolution Medicines, Inc.'s restricted cash?
- Revolution Medicines, Inc. (RVMD) reported restricted cash of $4.86M in Q2 2026.
- How has Revolution Medicines, Inc.'s restricted cash changed year-over-year?
- Revolution Medicines, Inc.'s restricted cash increased by 24.1% year-over-year, from $3.92M to $4.86M.
- What is the long-term trend for Revolution Medicines, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s restricted cash has grown at a 35.0% compound annual growth rate (CAGR), from $1.08M to $4.86M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Revolution Medicines, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude